# David P. Walling, Ph.D. – FDA Inspection, May 14, 2021

Source: https://www.keypedia.com/records/fda_inspections/david-p-walling-phd/54182797-6a79-4873-bd3e-4a0388d50a92
Source feed: FDA_Inspections

> FDA inspection 1143823 of David P. Walling, Ph.D., May 14, 2021. Classification: No Action Indicated (NAI). 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1143823
- Company Name: David P. Walling, Ph.D.
- Inspection Date: 2021-05-14
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1195349 - 2023-01-13](https://www.keypedia.com/records/fda_inspections/david-p-walling-phd/57c57951-6596-4170-b00f-3c4d9f4e7df5)
- FDA Inspection 1063079 - 2018-03-19
- FDA Inspection 917428 - 2015-03-11
- FDA Inspection 911140 - 2015-01-23
- FDA Inspection 879347 - 2014-05-09

Company: https://www.keypedia.com/companies/david-p-walling-phd/9e1c45b0-e599-4f02-b965-72551a0d70b6

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c